BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38370385)

  • 1. High CD204
    Xie Y; Tang G; Xie P; Zhao X; Chen C; Li X; Zhang Y; Wang B; Luo Y
    J Cancer; 2024; 15(6):1511-1522. PubMed ID: 38370385
    [No Abstract]   [Full Text] [Related]  

  • 2. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
    Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
    BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
    Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
    J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
    Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
    Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
    Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
    Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
    Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
    Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between CD204
    Kurdi M; Alghamdi B; Butt NS; Baeesa S
    Discov Oncol; 2021 Aug; 12(1):28. PubMed ID: 35201470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder.
    Wang B; Liu H; Dong X; Wu S; Zeng H; Liu Z; Wan D; Dong W; He W; Chen X; Zheng L; Huang J; Lin T
    Oncotarget; 2015 Aug; 6(24):20204-14. PubMed ID: 26001293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD204⁺ tumor-associated macrophages are associated with clinical outcome in canine pulmonary adenocarcinoma and transitional cell carcinoma.
    Yokota S; Kaji K; Yonezawa T; Momoi Y; Maeda S
    Vet J; 2023; 296-297():105992. PubMed ID: 37164121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
    Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Tumor-Associated Macrophages in Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Shen H; Liu J; Chen S; Ma X; Ying Y; Li J; Wang W; Wang X; Xie L
    Front Oncol; 2021; 11():657318. PubMed ID: 34026635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
    Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
    BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
    Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-associated CD204
    Sørensen MD; Kristensen BW
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12772. PubMed ID: 34713474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system.
    Nam SJ; Kim S; Kwon D; Kim H; Kim S; Lee E; Kim TM; Heo DS; Park SH; Lim MS; Kim CW; Jeon YK
    Oncoimmunology; 2018; 7(7):e1442164. PubMed ID: 29900049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.